We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Patenting RNA Interference Technology

Law360 (May 10, 2005, 12:00 AM EDT) -- RNA interference technology initiates degradation of specific messenger RNA (mRNA) and prevents production of the protein which the mRNA encodes.  This technology shows promise both for treating disease and creating models of disease.  Now that the technology is generally known, can a company patent its own particular application?


As with all patent applications, the company must demonstrate that its RNA interference technology has utility, is adequately described in the specification of the patent application, and is both novel and nonobvious.  The United States Patent and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.